Risk of CRC, Non-CRC Death Up With Positive Fecal Hb Test

Share this content:
Risk of CRC, Non-CRC Death Up With Positive Fecal Hb Test
Risk of CRC, Non-CRC Death Up With Positive Fecal Hb Test

WEDNESDAY, July 18, 2018 (HealthDay News) -- Individuals with a positive fecal hemoglobin (f-Hb) test result have an increased risk of dying from colorectal cancer (CRC) and non-CRC causes, according to a study published online July 16 in Gut.

Gillian Libby, from Ninewells Hospital and Medical School in Dundee, U.K., and colleagues examined the correlation between f-Hb, as indicated by a positive guaiac fecal occult blood test (gFOBT) result, and different causes of death. Data were included for 134,192 individuals who participated in gFOBT screening between March 29, 2000, and March 29, 2016. Their test results were linked with mortality data from the National Records of Scotland database.

Compared to individuals with a negative test result, the researchers found that the risk of dying from both CRC (hazard ratio, 7.79, after adjustment for gender, age, deprivation quintile, and medication that can cause bleeding) and all non-CRC causes (hazard ratio, 1.58) (both P < 0.0001) was higher for the 2,714 individuals with a positive test result. There was also a significant correlation for f-Hb detectable by gFOBT with increased risk of dying from circulatory disease, respiratory disease, digestive diseases (excluding CRC), neuropsychological disease, blood and endocrine disease, and non-CRCs.

"The presence of detectable f-Hb is associated with increased risk of death from a wide range of causes," the authors write.

Abstract/Full Text
Editorial

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »